Literature DB >> 10683378

Neointima formation in a restenosis model is suppressed in midkine-deficient mice.

M Horiba1, K Kadomatsu, E Nakamura, H Muramatsu, S Ikematsu, S Sakuma, K Hayashi, Y Yuzawa, S Matsuo, M Kuzuya, T Kaname, M Hirai, H Saito, T Muramatsu.   

Abstract

Neointima formation is a common feature of atherosclerosis and restenosis after balloon angioplasty. To find a new target to suppress neointima formation, we investigated the possible role of midkine (MK), a heparin-binding growth factor with neurotrophic and chemotactic activities, in neointima formation. MK expression increased during neointima formation caused by intraluminal balloon injury of the rat carotid artery. Neointima formation in a restenosis model was strongly suppressed in MK-deficient mice. Continuous administration of MK protein to MK-deficient mice restored neointima formation. Leukocyte recruitment to the vascular walls after injury was markedly decreased in MK-deficient mice. Soluble MK as well as that bound to the substratum induced migration of macrophages in vitro. These results indicate that MK plays a critical role in neointima formation at least in part owing to its ability to mediate leukocyte recruitment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683378      PMCID: PMC289157          DOI: 10.1172/JCI7208

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

Review 1.  The intima. Soil for atherosclerosis and restenosis.

Authors:  S M Schwartz; D deBlois; E R O'Brien
Journal:  Circ Res       Date:  1995-09       Impact factor: 17.367

2.  Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.

Authors:  F Czubayko; A M Schulte; G J Berchem; A Wellstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow.

Authors:  A Kumar; V Lindner
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

4.  Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro.

Authors:  N Kaneda; A H Talukder; H Nishiyama; S Koizumi; T Muramatsu
Journal:  J Biochem       Date:  1996-06       Impact factor: 3.387

5.  Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces.

Authors:  H Fukazawa; S Nakano; S Mizuno; Y Uehara
Journal:  Int J Cancer       Date:  1996-09-17       Impact factor: 7.396

6.  Differential expression of pleiotrophin and midkine in advanced neuroblastomas.

Authors:  A Nakagawara; J Milbrandt; T Muramatsu; T F Deuel; H Zhao; A Cnaan; G M Brodeur
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

7.  The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells.

Authors:  H B Peng; A A Ali; Z Dai; D F Daggett; E Raulo; H Rauvala
Journal:  J Neurosci       Date:  1995-04       Impact factor: 6.167

8.  Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group.

Authors:  H Emanuelsson; K J Beatt; J P Bagger; R Balcon; J Heikkilä; J Piessens; M Schaeffer; H Suryapranata; M Foegh
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

9.  Midkine induces the transformation of NIH3T3 cells.

Authors:  K Kadomatsu; M Hagihara; S Akhter; Q W Fan; H Muramatsu; T Muramatsu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Expression of midkine in the early stage of carcinogenesis in human colorectal cancer.

Authors:  C Ye; M Qi; Q W Fan; K Ito; S Akiyama; Y Kasai; M Matsuyama; T Muramatsu; K Kadomatsu
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

View more
  55 in total

1.  Nuclear targeting by the growth factor midkine.

Authors:  Yoshihisa Shibata; Takashi Muramatsu; Makoto Hirai; Tatsuya Inui; Terutoshi Kimura; Hidehiko Saito; Lynn M McCormick; Guojun Bu; Kenji Kadomatsu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 2.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

3.  Exogenous midkine administration prevents cardiac remodeling in pacing-induced congestive heart failure of rabbits.

Authors:  Masahide Harada; Mayumi Hojo; Kaichiro Kamiya; Kenji Kadomatsu; Toyoaki Murohara; Itsuo Kodama; Mitsuru Horiba
Journal:  Heart Vessels       Date:  2014-08-26       Impact factor: 2.037

Review 4.  Midkine in host defence.

Authors:  A Gela; S Jovic; S L Nordin; A Egesten
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 5.  A comparative anatomic and physiologic overview of the porcine heart.

Authors:  Pavlos P Lelovas; Nikolaos G Kostomitsopoulos; Theodoros T Xanthos
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

6.  PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells.

Authors:  Hanying Zhang; Miyako Okamoto; Evgeniy Panzhinskiy; W Michael Zawada; Mita Das
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-05       Impact factor: 4.249

Review 7.  Therapeutic potential of midkine in cardiovascular disease.

Authors:  Kenji Kadomatsu; Péter Bencsik; Anikó Görbe; Csaba Csonka; Kazuma Sakamoto; Satoshi Kishida; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 8.  Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.

Authors:  D R Jones
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 9.  Midkine and multiple sclerosis.

Authors:  Hideyuki Takeuchi
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  Midkine inhibitors: application of a simple assay procedure to screening of inhibitory compounds.

Authors:  Takashi Matsui; Keiko Ichihara-Tanaka; Chen Lan; Hisako Muramatsu; Toshiharu Kondou; Chizuru Hirose; Sadatoshi Sakuma; Takashi Muramatsu
Journal:  Int Arch Med       Date:  2010-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.